VANCOUVER and SAN DIEGO, May 4 /PRNewswire-FirstCall/ - MIGENIX Inc. (TSX: MGI - News; OTC: MGIFF - News), a clinical-stage developer of drugs for infectious diseases, has issued its 20th CEO Message from Jim DeMesa, MD, President & CEO. Today's CEO Message provides a review of several recent news events, and a summary of the Company's upcoming key milestones including:
